WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced the release of Central Designer, a next-generation product designed to help life sciences companies streamline their study development process by adding advanced functionality that enhances design efficiency and study component reuse, improves global collaboration and workflow, and provides an efficient way to incorporate standards. The new product, available immediately, surpasses the capabilities of the current generation of design tools through technical innovation and by drawing on Phase Forward’s vast experience in designing and building clinical trials.
